SCHEMBL23735698

SCHEMBL23735698

Cc1cc(O)cc2ccc(Cl)cc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.46
CHRM1 P11229 1/20 0.46
ALOX15 P16050 1/20 0.46
MAOA P21397 1/20 0.46
TBXA2R P21731 1/20 0.46
ADRA1A P35348 1/20 0.46
HTR2B P41595 1/20 0.46
POLB P06746 1/20 0.43
LMNA P02545 1/20 0.42
NPFFR1 Q9GZQ6 1/20 0.41
NPFFR2 Q9Y5X5 1/20 0.41
ALDH1A1 P00352 1/20 0.41
ESR1 P03372 2/20 0.41
ESR2 Q92731 2/20 0.41
CYP2A6 P11509 1/20 0.40
TP53 P04637 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
NOX1 Q9Y5S8 1/20 0.37
NQO2 P16083 1/20 0.36
DYRK1A Q13627 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9623383 0.81 ESR2 (0.52) CYP3A4CHRM1ALOX15MAOATBXA2R
SCHEMBL12962944 0.79 CYP1A2 (0.52) CYP3A4CHRM1ALOX15MAOATBXA2R
SCHEMBL22275374 0.79 NQO2 (0.54) CYP3A4ALOX15LMNAALDH1A1ESR1
SCHEMBL21240955 0.79 CYP2A6 (0.54) CYP3A4POLBLMNANPFFR1NPFFR2
SCHEMBL24448635 0.76 ESR1 (0.39) CYP3A4CHRM1ALOX15MAOATBXA2R
SCHEMBL30077833 0.76 NQO2 (0.36) CYP3A4ALOX15ALDH1A1ESR1ESR2
SCHEMBL20315029 0.76 GABRA1 (0.42) LMNAALDH1A1ESR1ESR2CYP2A6
SCHEMBL11216337 0.76 ESR1 (0.55) CYP3A4ALOX15LMNAESR1ESR2
SCHEMBL12822316 0.74 CYP2A6 (0.39) CYP3A4POLBLMNANPFFR1NPFFR2
SCHEMBL22435494 0.73 POLB (0.41) CYP3A4POLBLMNANPFFR1NPFFR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3558955-B1 BENZISOTHIAZOLE, ISOTHIAZOLO[3,4-B]PYRIDINE, QUINAZOLINE, PHTHALAZINE, PYRIDO[2,3-D]PYRIDAZINE AND PYRIDO[2,3-D]PYRIMIDINE DERIVATIVES AS KRAS G12C INHIBITORS FOR TREATING LUNG, PANCREATIC OR COLORECTAL CANCER AMGEN INC (US) 2021-08-11 EP disclosed